Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis

Pediatrics International

Volumn 49, Issue 3, 2007, Pages 349-354

  Chang, Jei Wen ^a,b,c   Yang, Ling Yu ^a,c   Wang, Hsin Hui ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Taoyuan Veterans Hospital   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Children; Focal segmental glomerulonephritis; Steroid resistant

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN; STEROID;

ALBUMIN BLOOD LEVEL; ARTICLE; AVASCULAR NECROSIS; BACTERIAL PERITONITIS; CATARACT; CHILD; CHINESE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE URINE LEVEL; DISEASE COURSE; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLUCOSURIA; GROWTH RETARDATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; KIDNEY FAILURE; LOW DRUG DOSE; MALE; NAUSEA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SEPSIS; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

BIOPSY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; REMISSION INDUCTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 34249052492     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02373.x     Document Type: Article

References (29)

1. Cameron JS, Tuner DR, Ogg CS. The long term prognosis of patients with focal segmental glomeruloclerosis. Clin. Nephrol. 1978 10 : 213 18.
2. Beaufils H, Alphonse JC, Geudon J, Legrain M. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 1978 21 : 75 85.
3. Cattran DC, Rao P. Long term outcome in children and adults with classic focal segmental glomerulosclerosis. Am. J. Kidney Dis. 1998 32 : 72 9.
4. Tune BM, Kirpekar R, Sibley RK, Renik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long term follow up. Clin. Nephrol. 1995 43 : 84 8.
5. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr. Nephrol. 1990 4 : 303 7.
6. Hari P, Bagga A, Jindal N, Srivastava RN. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr. Nephrol. 2001 6 : 901 5.
7. Griswold WR, Tune BM, Reznik VM et al. Treatment of childhood prednisolone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron 1987 46 : 73 7.
8. Waldo FB, Benfeild MR, Kohaut EC. Methylprednisolone treatment of patients with steroid resistant nephrotic syndrome. Pediatr. Nephrol. 1992 6 : 503 5.
9. Fan PT, Yu DT, Targoff C, Bluestone R. Effect of corticosteroids on the human immune response. Suppression of mitogen-induced lymphocyte proliferation by "pulse" methylprednisolone. Transplantation 1978 26 : 266 7.
10. Yorgin PD, Krasher J, Al-Uzri AY. Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 2001 16 : 245 50.
11. Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R. Primary focal segmental glomerular sclerosis in adult. Prognosis value of histologic variants. Am. J. Kidney Dis. 1995 25 : 845 52.
12. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler Hl. Long-term prognosis of focal sclerosis glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin. Nephrol. 1990 33 : 115 22.
13. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr. Nephrol. 1991 5 : 393 7.
14. Ito H, Yoshikawa N, Aozai F et al. Twenty-seven children with focal segmental glomerulosclerosis: correlation between the segmental location of the glomerular lesion and prognosis. Clin. Nephrol. 1984 22 : 9 14.
15. Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int. 1999 56 : 2236 4.
16. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 2000 24 : 349 54.
17. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 2000 24 : 251 6.
18. Brenchley PEC. Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2003 18 (Suppl 6 vi21 5.
19. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med. 1996 334 : 873 83.
20. Parrillo JE, Fauci AS. Mechanism of glucocorticoid action on immune process. Annu. Rev. Pharmacol. Toxicol. 1979 19 : 179 201.
21. Misra RP, Berman LB. Studies on glomerular basement membrane. III. Effects of steroid on membrane chemistry and its protein permeability. Lab. Invest. 1972 26 : 666 70.
22. Joles JA, Rabelink TJ, Braam B, Koomans HA. Plasma volume regulation: defenses against edema formation (with special emphasis on hypoproteinemia). Am. J. Nephrol. 1993 13 : 399 412.
23. Wang SS, Tsau YK, Lu FL, Chen CH. Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr. Taiwan 2000 41 : 179 83.
24. Vande Walle JG, Donckerwolcke RAMG, Wilmersma Greidanus TB, Joles JA, Koomans HA. Renal sodium handling in children with nephrotic relapse: relation to hypovolemic symptoms. Nephrol. Dial. Transplant. 1996 11 : 2202 8.
25. Meyruer A. Nephrotic focal segmental glomerulosclerosis in 2004: an update. Nephrol. Dial. Transplant. 2004 19 : 2437 44.
26. Tune BM, Lieberman E, Mendoza SA. Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr. Nephrol. 1996 10 : 772 8.
27. Meyrier A. Antiproteinuric and immunologic effects of cyclosporine A in the treatment of glomerular diseases. Nephrol. Dial. Transplant. 1992 7 : 80 4.
28. Zietse R, Wenting GJ, Kramer P, Schalekamp MADH, Weimar W. Effects of cyclosporine A on glomerular barrier function in the nephrotic syndrome. Clin. Sci. 1992 82 : 641 50.
29. Korbert SM. Treatment of primary focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 2002 62 : 2301 10.